169 related articles for article (PubMed ID: 34411980)
1. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide.
El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H
Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and pharmacological evaluation of some substituted dihydropyrimidines with L-/T-type calcium channel blocking activities.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Mar; 83():354-366. PubMed ID: 30408648
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of some new C2 substituted dihydropyrimidines and their electrophysiological evaluation as L-/T-type calcium channel blockers.
Teleb M; Rizk OH; Zhang FX; Fronczek FR; Zamponi GW; Fahmy H
Bioorg Chem; 2019 Jul; 88():102915. PubMed ID: 31005784
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic effects of 2-thio-3,4-dihydroquinazoline derivatives as novel T-type calcium channel blockers.
Nam Y; Ryu KD; Jang C; Moon YH; Kim M; Ko D; Chung KS; Gandini MA; Lee KT; Zamponi GW; Lee JY
Bioorg Med Chem; 2020 Jun; 28(11):115491. PubMed ID: 32327350
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of new N3-substituted dihydropyrimidine derivatives as L-/T- type calcium channel blockers.
Teleb M; Zhang FX; Farghaly AM; Aboul Wafa OM; Fronczek FR; Zamponi GW; Fahmy H
Eur J Med Chem; 2017 Jul; 134():52-61. PubMed ID: 28399450
[TBL] [Abstract][Full Text] [Related]
7. In vitro synergistic anticancer activity of the combination of T-type calcium channel blocker and chemotherapeutic agent in A549 cells.
Byun JS; Sohn JM; Leem DG; Park B; Nam JH; Shin DH; Shin JS; Kim HJ; Lee KT; Lee JY
Bioorg Med Chem Lett; 2016 Feb; 26(3):1073-1079. PubMed ID: 26739776
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibition of human cancer cells in vitro by T-type calcium channel blockers.
Lee JY; Park SJ; Park SJ; Lee MJ; Rhim H; Seo SH; Kim KS
Bioorg Med Chem Lett; 2006 Oct; 16(19):5014-7. PubMed ID: 16876410
[TBL] [Abstract][Full Text] [Related]
9. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Ertel EA; Moon R; Mawet J; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5326-5331. PubMed ID: 29074257
[TBL] [Abstract][Full Text] [Related]
10. Binding mechanism investigations guiding the synthesis of novel condensed 1,4-dihydropyridine derivatives with L-/T-type calcium channel blocking activity.
Schaller D; Gündüz MG; Zhang FX; Zamponi GW; Wolber G
Eur J Med Chem; 2018 Jul; 155():1-12. PubMed ID: 29843108
[TBL] [Abstract][Full Text] [Related]
11. Discovery and evaluation of Ca
Bezençon O; Remeň L; Richard S; Roch C; Kessler M; Moon R; Mawet J; Ertel EA; Pfeifer T; Capeleto B
Bioorg Med Chem Lett; 2017 Dec; 27(23):5322-5325. PubMed ID: 29066309
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
13. T-type Ca2+ channel blockers suppress the growth of human cancer cells.
Heo JH; Seo HN; Choe YJ; Kim S; Oh CR; Kim YD; Rhim H; Choo DJ; Kim J; Lee JY
Bioorg Med Chem Lett; 2008 Jul; 18(14):3899-901. PubMed ID: 18585035
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, ADMET prediction and reverse screening study of 3,4,5-trimethoxy phenyl ring pendant sulfur-containing cyanopyrimidine derivatives as promising apoptosis inducing anticancer agents.
Nainwal LM; Shaququzzaman M; Akhter M; Husain A; Parvez S; Khan F; Naematullah M; Alam MM
Bioorg Chem; 2020 Nov; 104():104282. PubMed ID: 33010624
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Pseudellone Analogs and Characterization as Novel T-type Calcium Channel Blockers.
Wang D; Neupane P; Ragnarsson L; Capon RJ; Lewis RJ
Mar Drugs; 2018 Nov; 16(12):. PubMed ID: 30487473
[TBL] [Abstract][Full Text] [Related]
16. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antitumor evaluation of novel 5-methylpyrazolo[1,5-a]pyrimidine derivatives as potential c-Met inhibitors.
Luo G; Ma Y; Liang X; Xie G; Luo Y; Zha D; Wang S; Yu L; Zheng X; Wu W; Zhang C
Bioorg Chem; 2020 Nov; 104():104356. PubMed ID: 33142417
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
20. Anti-proliferative potential of triphenyl substituted pyrimidines against MDA-MB-231, HCT-116 and HT-29 cancer cell lines.
Ranjan Dwivedi A; Kumar V; Kaur H; Kumar N; Prakash Yadav R; Poduri R; Baranwal S; Kumar V
Bioorg Med Chem Lett; 2020 Oct; 30(20):127468. PubMed ID: 32768647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]